Lee Financial CO Repligen Corp Transaction History

Lee Financial CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $1,542 - $1,981	10 New	10 $1,000
Q1 2022 May 11, 2022	SELL	$161.19 - $257.96 $7,414 - $11,866	-46 Reduced 80.7%	11 $2,000
Q4 2021 Feb 08, 2022	BUY	$247.59 - $304.47 $11,389 - $14,005	46 Added 418.18%	57 $15,000
Q2 2021 Aug 04, 2021	BUY	$165.87 - $220.95 $1,824 - $2,430	11 New	11 $2,000
Q4 2017 Feb 09, 2018	SELL	$32.53 - $38.92 $7,319 - $8,757	-225 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$36.98 - $46.06 $8,320 - $10,363	225	225 $9,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.